1. Bisindole natural products: A vital source for the development of new anticancer drugs
   Mengwei Xu et al, 2022, European Journal of Medicinal Chemistry CrossRef
2. The interplay of CDK4 and CDK6 in melanoma
   Karoline Kollmann et al, 2019, Oncotarget CrossRef
3. Basic Pan-Cancer Analysis of the Carcinogenic Effects of Cyclin-Dependent Kinase 4 (CDK4) in Human Surface Tumors
   Jingping Wu et al, 2021, Journal of Healthcare Engineering CrossRef
4. Marine-Derived Lead Fascaplysin: Pharmacological Activity, Total Synthesis, and Structural Modification
   Chao Wang et al, 2023, Marine Drugs CrossRef
5. Marine-Derived Bisindoles for Potent Selective Cancer Drug Discovery and Development
   Mengwei Xu et al, 2024, Molecules CrossRef
6. The Melding of Drug Screening Platforms for Melanoma
   Gabriela Klein Couto et al, 2019, Frontiers in Oncology CrossRef
7. Fluorescent peptide biosensor for monitoring CDK4/cyclin D kinase activity in melanoma cell extracts, mouse xenografts and skin biopsies
   Camille Prével et al, 2016, Biosensors and Bioelectronics CrossRef
8. Lanthanide-based peptide biosensor to monitor CDK4/cyclin D kinase activity
   Juan A. González-Vera et al, 2017, Chemical Communications CrossRef
9. Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK
   Taek-In Oh et al, 2017, Molecules CrossRef
10. Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer
    Alexandra Canonici et al, 2020, Therapeutic Advances in Medical Oncology CrossRef
11. Roles and mechanisms of aberrant alternative splicing in melanoma — implications for targeted therapy and immunotherapy resistance
    Wanxian Chen et al, 2024, Cancer Cell International CrossRef
12. Comparison of the Inhibitory Binding Modes Between the Planar Fascaplysin and Its Nonplanar Tetrahydro-β-carboline Analogs in CDK4
    Yan Liang et al, 2021, Frontiers in Chemistry CrossRef
13. A New Mild Method for Synthesis of Marine Alkaloid Fascaplysin and Its Therapeutically Promising Derivatives
    Oleg A. Tryapkin et al, 2023, Marine Drugs CrossRef
14. Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma
    Shatha AbuHammad et al, 2019, Proceedings of the National Academy of Sciences CrossRef
15. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4
    Junhu Wan et al, 2019, International Journal of Cancer CrossRef
16. Jumonji domain‐containing protein 6 protein and its role in cancer
    Jing Yang et al, 2020, Cell Proliferation CrossRef
17. Protein kinase inhibitors and cancer targeted therapy
    Azadeh Hekmat et al, 2022, Protein Kinase Inhibitors CrossRef
18. Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4
    Shuo Chen et al, 2017, Gene CrossRef
19. Profiling of prognostic alternative splicing in melanoma
    Fu‑Chao Ma et al, 2019, Oncology Letters CrossRef